How many insider trades does FilingIQ track for CVKD?

FilingIQ tracks 61 Form 4 insider transactions for CVKD (Cadrenal Therapeutics, Inc.), covering filings from Jan 24, 2023 onwards. 20 of those were filed in the last 90 days.

Are CVKD insiders net buyers or net sellers?

Across the full Form 4 history for CVKD, 11 transactions (18%) were open-market purchases and 43 (70%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CVKD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CVKD in?

Cadrenal Therapeutics, Inc. (CVKD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $12.67M.

CVKD insider trading

NasdaqCM Healthcare

Cadrenal Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

18% / 70%

Market cap

$12.67M

About Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Company website: www.cadrenal.com

CVKD insider activity at a glance

FilingIQ has scored 61 insider transactions for CVKD since Jan 24, 2023. The most recent filing in our index is dated Jun 29, 2026.

Across the full history, 11 open-market purchases and 43 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CVKD insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CVKD trades on FilingIQ Raw filings on SEC EDGAR

Latest CVKD Form 4 filings

Pham Quang X Chairman, CEO and Interim CFO

S Jun 12, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,099

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 232

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Top insiders trading CVKD

Pham Quang X

27 trades · score 73.0

Frequently asked

How many insider trades does FilingIQ track for CVKD?: FilingIQ tracks 61 Form 4 insider transactions for CVKD (Cadrenal Therapeutics, Inc.), covering filings from Jan 24, 2023 onwards. 20 of those were filed in the last 90 days.
Are CVKD insiders net buyers or net sellers?: Across the full Form 4 history for CVKD, 11 transactions (18%) were open-market purchases and 43 (70%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CVKD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CVKD in?: Cadrenal Therapeutics, Inc. (CVKD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $12.67M.

Methodology & sources

Every CVKD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.